معرفی
Amanda Sathyapala serves as Clinical Associate Professor in the Airways Disease Section of Imperial College London's National Heart & Lung Institute (Faculty of Medicine) and holds dual clinical appointments as Consultant Respiratory Physician and Clinical Lead of the Home Ventilation Service at Harefield Hospital. Her clinical expertise spans sleep-disordered breathing including obstructive sleep apnea (OSA), hypoventilation syndromes, chronic respiratory failure, and home nocturnal non-invasive ventilation management.
Dr. Sathyapala's educational journey includes:
- First Class Honours in Medicine at Cambridge University (1993–96) and Oxford University (1996–99)
- Intercalated BSc in Experimental Psychology (First Class)
- Junior doctor training across Oxford/London institutions
- Specialist Respiratory & General Internal Medicine training in North-West Thames region (Hammersmith, Harefield, Royal Brompton Hospitals)
- PhD (2011) through Wellcome Trust Clinical Research Training Fellowship under Professor Mike Polkey at Royal Brompton Hospital with international component at Maastricht University
Her research focuses on two critical areas: (1) Addressing low CPAP adherence rates (27-51%) in UK OSA patients through behavioral interventions delivered via digital platforms; (2) Investigating molecular mechanisms of skeletal muscle dysfunction in COPD and chronic diseases to identify drug targets for exercise intolerance. This work directly tackles frailty in aging populations, evidenced by her 2016 international symposium on 'Skeletal muscle oxidative metabolism as a target for treating human disease'.
Key accolades include:
- Wellcome Trust Clinical Research Training Fellowship
- HEFCE Clinical Senior Lectureship (2012–present)
- Election as Fellow of the Royal College of Physicians (April 2015)
Dr. Sathyapala actively shapes national research policy as Research Committee Lead and Executive Board member of the British Sleep Society, serves on the NIHR RfPB London Regional Advisory Committee, reviews for leading respiratory journals and the BMJ, and provides pharmaceutical advisory services to Lilly on OSA medications. Her HEFCE Senior Lectureship supports her dual principal investigator role at NHLI while Wellcome Trust funding enabled her foundational PhD research.
She leads a dedicated research group within NHLI's Airways Disease Section that bridges clinical practice and laboratory investigation, maintaining international collaborations evidenced by her Maastricht University affiliation during doctoral studies. Her team's current priority is implementing smartphone-based behavioral interventions for CPAP adherence while continuing mechanistic studies on skeletal muscle metabolism through symposia and cross-disciplinary partnerships.
